Used in pharmaceutical synthesis as a key intermediate for developing neuroactive compounds, particularly in the production of selective receptor agonists and antagonists targeting central nervous system disorders. Its structure supports binding to nicotinic acetylcholine receptors, making it valuable in research on cognitive enhancement, pain management, and psychiatric conditions such as depression and schizophrenia. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its fluorinated aromatic core and functionalized piperidine moiety. Also utilized in the development of positron emission tomography (PET) tracers for brain imaging when labeled with fluorine-18.